Cartesian Therapeutics, Inc. (RNAC) Stock Total Returns
Growth of $10,000 chart
2021-04-21 to 2026-04-21 to
$
%
%
Loading chart…
Investment Performance
Final Value
$600
Total Return
-94.00%
CAGR
-43.04%
Dividends
$0.00
Yield on Cost
0.00%
Rolling Returns
1-Month (21 Trading Days)
| Average | -1.85% |
| Median | -5.95% |
| Best | +93.39% |
| Worst | -54.58% |
| % of Windows Positive | 37.8% |
1-Year (252 Trading Days)
| Average | -39.59% |
| Median | -44.43% |
| Best | +72.11% |
| Worst | -82.88% |
| % of Windows Positive | 5.5% |
3-Year (756 Trading Days)
| Average | -78.16% |
| Median | -80.97% |
| Best | -44.15% |
| Worst | -90.63% |
| % of Windows Positive | 0.0% |
Risk Metrics
| Maximum Drawdown | -96.11% |
| Average Drawdown | -73.06% |
| Drawdown Duration | 1217 Trading Days (Unrecovered) |
| Sortino Ratio | -0.29 |
| Calmar Ratio | -0.45 |
| CVaR (5%) | -11.71% |
Yearly Returns
| Year | Percentage | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|
| 2026 partial | -4.16% (-13.06% ann.) | $416.50 | $0.00 | $0.00 | $0.00 |
| 2025 | -59.74% | $5974.25 | $0.00 | $0.00 | $0.00 |
| 2024 | -13.35% | $1335.19 | $0.00 | $0.00 | $0.00 |
| 2023 | -39.03% | $3902.67 | $0.00 | $0.00 | $0.00 |
| 2022 | -65.34% | $6533.75 | $0.00 | $0.00 | $0.00 |
| 2021 | +7.59% | +$759.05 | $0.00 | $0.00 | $0.00 |
| 2020 | +27.31% | +$2731.12 | $0.00 | $0.00 | $0.00 |
| 2019 | -10.53% | $1052.63 | $0.00 | $0.00 | $0.00 |
| 2018 | -72.88% | $7288.48 | $0.00 | $0.00 | $0.00 |
| 2017 | -42.80% | $4279.89 | $0.00 | $0.00 | $0.00 |
| 2016 partial | +22.50% (+47.42% ann.) | +$2250.00 | $0.00 | $0.00 | $0.00 |
Market Regimes
about| Regime | Period | Percentage | Annual | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|---|---|
| Secular stagnation / QE / low inflation / duration bull partial | June 22, 2016 – February 19, 2020 | -67.86% | -26.66% | $6785.71 | $0.00 | $0.00 | $0.00 |
| Pandemic shock / liquidity crash | February 20, 2020 – March 23, 2020 | -54.33% | -99.99% | $5433.25 | $0.00 | $0.00 | $0.00 |
| Policy bazooka / monetary euphoria | March 24, 2020 – November 6, 2020 | +55.38% | +103.23% | +$5538.46 | $0.00 | $0.00 | $0.00 |
| Reopening reflation / fiscal boom / supply bottlenecks | November 9, 2020 – November 29, 2021 | -3.28% | -3.11% | $327.88 | $0.00 | $0.00 | $0.00 |
| Inflation shock / duration crash / aggressive tightening | November 30, 2021 – November 9, 2022 | -52.67% | -54.80% | $5266.65 | $0.00 | $0.00 | $0.00 |
| Disinflation rebound / AI-led narrow bull / higher-for-longer | November 10, 2022 – September 17, 2024 | -62.29% | -40.91% | $6229.05 | $0.00 | $0.00 | $0.00 |
| Disinflationary easing / resilient growth / AI capex under oil-shock test partial | September 18, 2024 – April 21, 2026 | -55.79% | -40.19% | $5579.08 | $0.00 | $0.00 | $0.00 |
Dividend History
| Date | Per Share | Yield % |
|---|---|---|
| Total | 0 payments |
No dividends recorded.
All calculations use split-adjusted closing prices. Dividends are reinvested on the ex-dividend date at that day's closing price.
For each rolling window, returns are calculated at every possible starting point:
return = (value[i] ÷ value[i − windowSize] − 1) × 100
- Windows
- 1-month = 21 trading days, 1-year = 252 trading days, 3-year = 756 trading days.
- Statistics
- Average: arithmetic mean. Median: middle value when sorted. Best / Worst: max and min. % Positive: share of windows with return > 0.
The series is segmented by calendar year:
return = (endValue ÷ startValue − 1) × 100
startValue is the last value of the prior year (or the first value for the initial year). Partial first/last years are flagged. Dividends, taxes, and transaction costs are scaled proportionally to the initial investment.